{"id":66881,"date":"2026-05-06T19:31:07","date_gmt":"2026-05-06T14:01:07","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=66881"},"modified":"2026-05-06T19:31:10","modified_gmt":"2026-05-06T14:01:10","slug":"anticoagulation-for-prosthetic-valve-in-pregnancy","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-prosthetic-valve-in-pregnancy\/","title":{"rendered":"Anticoagulation for prosthetic valve in pregnancy"},"content":{"rendered":"<iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/CkVPiTKdut4?si=wSr_5lUH-rHOlS6-\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n\n<p class=\"wp-block-paragraph\">Managing anticoagulation for a mechanical prosthetic valve during pregnancy is one of the most complex scenarios in cardio-obstetrics. The primary challenge is balancing the <strong>maternal risk<\/strong> of valve thrombosis and systemic embolism against the <strong>fetal risk<\/strong> of embryopathy and hemorrhage.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">1. The Core Dilemma: Warfarin vs. Heparin<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Vitamin K Antagonists (VKAs) like Warfarin:<\/strong> These are the most effective agents for preventing maternal mechanical prosthetic valve thrombosis. However, they cross the placenta and can cause <strong>warfarin embryopathy<\/strong> (especially between weeks 6 and 12) and fetal intracranial hemorrhage.<\/li>\n\n\n\n<li class=\"\"><strong>Low Molecular Weight Heparin (LMWH) \/ Unfractionated Heparin (UFH):<\/strong> These do not cross the placenta and are safe for the fetus. However, they are associated with a higher risk of maternal valve thrombosis compared to VKAs, particularly if monitoring is not stringent.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">2. Management by Trimester<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">First Trimester (Weeks 1\u201312)<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The strategy often depends on the daily dose of Warfarin required to maintain a therapeutic INR:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Low Dose Warfarin (\u2264 5 mg\/day):<\/strong> Many guidelines suggest continuing Warfarin through the first trimester, as the risk of embryopathy is low (&lt; 3%) at these doses, and maternal protection is superior.<\/li>\n\n\n\n<li class=\"\"><strong>High Dose Warfarin (> 5 mg\/day):<\/strong> There is a higher risk of embryopathy. Options include:\n<ol start=\"1\" class=\"wp-block-list\">\n<li class=\"\">Continuing Warfarin (<strong>after informed consent regarding fetal risks<\/strong>).<\/li>\n\n\n\n<li class=\"\">Switching to dose-adjusted <strong>LMWH<\/strong> (twice daily) or <strong>UFH<\/strong> between weeks 6 and 12, then reverting to Warfarin.<\/li>\n<\/ol>\n<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Second and Third Trimesters (Until Week 36)<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>VKAs<\/strong> are generally recommended for all patients during this period. They provide the most stable anticoagulation and the fetal risk (other than minor bleeding) is significantly lower after the first trimester organogenesis is complete.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Delivery (Week 36 onwards)<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\">Patients should be switched from VKAs to <strong>LMWH<\/strong> or <strong>continuous IV UFH<\/strong> around week 36.<\/li>\n\n\n\n<li class=\"\">VKAs must be stopped well before delivery to allow fetal clotting factors to normalize, reducing the risk of fetal intracranial hemorrhage during vaginal birth.<\/li>\n\n\n\n<li class=\"\"><strong>UFH<\/strong> is typically stopped 4\u20136 hours before expected delivery and restarted 4\u20136 hours after, provided there are no bleeding complications.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">3. Monitoring and Targets<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>VKA\/Warfarin:<\/strong> Maintain the INR within the target range recommended for the specific valve type and location (e.g., mitral valves generally require a higher INR than aortic valves).<\/li>\n\n\n\n<li class=\"\"><strong>LMWH:<\/strong> Monitoring is <strong>mandatory<\/strong>. Peak anti-Xa levels should be checked weekly (aiming for 0.8\u20131.2 IU\/mL for most mechanical valves). Some centers also monitor trough levels (aiming for > 0.6 IU\/mL). This monitoring may not be universally available.<\/li>\n\n\n\n<li class=\"\"><strong>DOACs:<\/strong> Direct Oral Anticoagulants are <strong>contraindicated<\/strong> in pregnancy and for mechanical valves in general.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">4. Summary Table of Risks<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>Approach<\/strong><\/td><td><strong>Maternal Risk (Thrombosis)<\/strong><\/td><td><strong>Fetal Risk (Embryopathy\/Bleed)<\/strong><\/td><\/tr><\/thead><tbody><tr><td><strong>VKA (All Trimesters)<\/strong><\/td><td>Lowest<\/td><td>Highest<\/td><\/tr><tr><td><strong>Heparin (1st Trim) \/ VKA (2nd &amp; 3rd)<\/strong><\/td><td>Moderate<\/td><td>Low<\/td><\/tr><tr><td><strong>Heparin (All Trimesters)<\/strong><\/td><td>Highest<\/td><td>Lowest<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><strong>Critical Note:<\/strong> All management plans must be individualized through a &#8220;Heart Team&#8221; approach involving a cardiologist, obstetrician, and hematologist. Frequent monitoring is the most vital component in preventing complications.<\/p>\n<\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\">ROPAC III<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><a href=\"https:\/\/academic.oup.com\/eurheartj\/article\/47\/11\/1318\/8114419\" type=\"link\" id=\"https:\/\/academic.oup.com\/eurheartj\/article\/47\/11\/1318\/8114419\">Pregnancy with a prosthetic heart valve, thrombosis, and bleeding: the ESC EORP Registry of Pregnancy and Cardiac disease III<\/a><\/strong>: The most recent global registry data from 613 pregnancies confirms that women with mechanical valves have significantly lower rates of uncomplicated live births (54%) compared to those with biological valves (79%). It also indicates that LMWH-based regimens are associated with higher rates of thromboembolic and hemorrhagic complications compared to VKA-based regimens. A mitral prosthetic valve was a predictor for valve thrombosis. Benefit in terms of reduced thromboembolic events from using anti-Xa level monitoring in women on LMWH could not be confirmed or refuted.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">ROPAC<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.ahajournals.org\/doi\/10.1161\/circulationaha.115.015242\" type=\"link\" id=\"https:\/\/www.ahajournals.org\/doi\/10.1161\/circulationaha.115.015242\">Pregnancy in Women With a Mechanical Heart Valve: Data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC)<\/a>: An earlier landmark analysis from the Registry of Pregnancy and Cardiac Disease that established the high risk of MHVs, noting a high incidence of maternal mortality and valve thrombosis in these patients. They concluded that women with mechanical heart valves have only a 58% chance of experiencing an uncomplicated pregnancy with a live birth. They suggested that the markedly increased mortality and morbidity warrant <strong>extensive prepregnancy counseling<\/strong> and centralization of care.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Managing anticoagulation for a mechanical prosthetic valve during pregnancy is one of the most complex scenarios in cardio-obstetrics. The primary challenge is balancing the maternal risk of valve thrombosis and systemic embolism against the fetal risk of embryopathy and hemorrhage. 1. The Core Dilemma: Warfarin vs. Heparin 2. Management by Trimester First Trimester (Weeks 1\u201312) [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":66884,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-66881","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Anticoagulation for prosthetic valve in pregnancy - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-prosthetic-valve-in-pregnancy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anticoagulation for prosthetic valve in pregnancy - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"Managing anticoagulation for a mechanical prosthetic valve during pregnancy is one of the most complex scenarios in cardio-obstetrics. The primary challenge is balancing the maternal risk of valve thrombosis and systemic embolism against the fetal risk of embryopathy and hemorrhage. 1. The Core Dilemma: Warfarin vs. Heparin 2. Management by Trimester First Trimester (Weeks 1\u201312) [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-prosthetic-valve-in-pregnancy\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-06T14:01:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-06T14:01:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Anticoagulation-for-prosthetic-valve-in-pregnancy-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-prosthetic-valve-in-pregnancy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-prosthetic-valve-in-pregnancy\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"Anticoagulation for prosthetic valve in pregnancy\",\"datePublished\":\"2026-05-06T14:01:07+00:00\",\"dateModified\":\"2026-05-06T14:01:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-prosthetic-valve-in-pregnancy\\\/\"},\"wordCount\":654,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-prosthetic-valve-in-pregnancy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Anticoagulation-for-prosthetic-valve-in-pregnancy-1.jpg\",\"articleSection\":[\"General Cardiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-prosthetic-valve-in-pregnancy\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-prosthetic-valve-in-pregnancy\\\/\",\"name\":\"Anticoagulation for prosthetic valve in pregnancy - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-prosthetic-valve-in-pregnancy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-prosthetic-valve-in-pregnancy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Anticoagulation-for-prosthetic-valve-in-pregnancy-1.jpg\",\"datePublished\":\"2026-05-06T14:01:07+00:00\",\"dateModified\":\"2026-05-06T14:01:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-prosthetic-valve-in-pregnancy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-prosthetic-valve-in-pregnancy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-prosthetic-valve-in-pregnancy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Anticoagulation-for-prosthetic-valve-in-pregnancy-1.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Anticoagulation-for-prosthetic-valve-in-pregnancy-1.jpg\",\"width\":1200,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/anticoagulation-for-prosthetic-valve-in-pregnancy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anticoagulation for prosthetic valve in pregnancy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anticoagulation for prosthetic valve in pregnancy - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-prosthetic-valve-in-pregnancy\/","og_locale":"en_US","og_type":"article","og_title":"Anticoagulation for prosthetic valve in pregnancy - All About Cardiovascular System and Disorders","og_description":"Managing anticoagulation for a mechanical prosthetic valve during pregnancy is one of the most complex scenarios in cardio-obstetrics. The primary challenge is balancing the maternal risk of valve thrombosis and systemic embolism against the fetal risk of embryopathy and hemorrhage. 1. The Core Dilemma: Warfarin vs. Heparin 2. Management by Trimester First Trimester (Weeks 1\u201312) [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-prosthetic-valve-in-pregnancy\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2026-05-06T14:01:07+00:00","article_modified_time":"2026-05-06T14:01:10+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Anticoagulation-for-prosthetic-valve-in-pregnancy-1.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-prosthetic-valve-in-pregnancy\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-prosthetic-valve-in-pregnancy\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"Anticoagulation for prosthetic valve in pregnancy","datePublished":"2026-05-06T14:01:07+00:00","dateModified":"2026-05-06T14:01:10+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-prosthetic-valve-in-pregnancy\/"},"wordCount":654,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-prosthetic-valve-in-pregnancy\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Anticoagulation-for-prosthetic-valve-in-pregnancy-1.jpg","articleSection":["General Cardiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-prosthetic-valve-in-pregnancy\/","url":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-prosthetic-valve-in-pregnancy\/","name":"Anticoagulation for prosthetic valve in pregnancy - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-prosthetic-valve-in-pregnancy\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-prosthetic-valve-in-pregnancy\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Anticoagulation-for-prosthetic-valve-in-pregnancy-1.jpg","datePublished":"2026-05-06T14:01:07+00:00","dateModified":"2026-05-06T14:01:10+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-prosthetic-valve-in-pregnancy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-prosthetic-valve-in-pregnancy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-prosthetic-valve-in-pregnancy\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Anticoagulation-for-prosthetic-valve-in-pregnancy-1.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Anticoagulation-for-prosthetic-valve-in-pregnancy-1.jpg","width":1200,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/anticoagulation-for-prosthetic-valve-in-pregnancy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"Anticoagulation for prosthetic valve in pregnancy"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/66881","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=66881"}],"version-history":[{"count":5,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/66881\/revisions"}],"predecessor-version":[{"id":66889,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/66881\/revisions\/66889"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media\/66884"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=66881"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=66881"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=66881"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}